Full-Time

Quality Engineer Principal

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Framingham, MA, USA + 1 more

More locations: Westborough, MA, USA

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor's degree in Science or Engineering and a minimum of 9 years’ experience working in a regulated, cGXP environment or Master's degree and a minimum of 6 years' experience working in a regulated, cGXP environment
  • Operations experience in one or more of the following areas with demonstrated knowledge of the validation lifecycle: Quality Assurance, Quality Control, Manufacturing Technical Support, Facilities Engineering, or Computer Systems/Automation
  • Demonstrated knowledge of cGXP regulations and guidance
  • Excellent technical writing skills
  • Direct experience with change control and CAPA quality systems
Responsibilities
  • Demonstrates strong leadership qualities and embodies Sanofi's core leadership principals
  • Performs timely and complete QA review and approval of validation lifecycle documents and determines interrelated impacts to processes and systems. Ensures completeness, timeliness and accuracy of documentation such as engineering studies, validation protocols/nonconformances/reports, technical reports, engineering drawings, and MBRs/SOPs.
  • Participates in Community of Practice discussions to share best practices and raise opportunities for simplification and harmonization
  • Partners with project teams to develop the implementation strategy and change control approach for complex projects with validation impact
  • Performs validation assessments for change control requests that comply with Sanofi and Biologics Quality standards, procedures and guidance
  • Leads or participates in gap assessments against Sanofi and Biologics Quality directives/standards and authors gap remediation plans
  • Authors or reviews validation section of annual periodic product reviews
  • Proactively identifies compliance risk and presents to cross-functional site risk review team or quality council, as appropriate
  • Applies Sanofi Manufacturing System (SMS) tools to daily ways of working in order to support a culture of continuous improvement
  • Supports external regulatory inspections through consultation with other Subject Matter Experts and direct interaction with investigators for requests within area of expertise. Leads or supports execution of CAPA for external regulatory commitments.
  • Participates in formal risk assessments
  • Demonstrates an ongoing commitment to conducting our global business according to the highest legal and ethical standards, and to continually pursue excellence in the development and delivery of all of our products and services. This includes: Adhering to all applicable laws and regulations of the places in which we conduct business, as well as our own Company policies and procedures. Being honest and treating people with respect and courtesy. Constantly striving to make Sanofi a great place to work, and a company respected for the quality of its people and products. Acting as role models for our fellow employees by acting responsibly, fairly, and honestly in our dealings and exercising sound judgment in performing our jobs.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval expands Sanofi's pediatric treatment offerings.
  • Sanofi's investment in Zucara Therapeutics strengthens its diabetes treatment pipeline.

What critics are saying

  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Competition in multiple sclerosis market could impact tolebrutinib's market share.
  • AI tools like Muse may face challenges from stringent data privacy regulations.

What makes Sanofi unique

  • Sanofi's partnership with BrightInsight enhances digital health solutions for specialty therapies.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?